Steven Sparenborg

1.8k total citations · 1 hit paper
29 papers, 1.2k citations indexed

About

Steven Sparenborg is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Steven Sparenborg has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Cognitive Neuroscience. Recurrent topics in Steven Sparenborg's work include Substance Abuse Treatment and Outcomes (6 papers), Memory and Neural Mechanisms (6 papers) and Opioid Use Disorder Treatment (5 papers). Steven Sparenborg is often cited by papers focused on Substance Abuse Treatment and Outcomes (6 papers), Memory and Neural Mechanisms (6 papers) and Opioid Use Disorder Treatment (5 papers). Steven Sparenborg collaborates with scholars based in United States and Spain. Steven Sparenborg's co-authors include Michael Gabriel, David J. Braitman, Michael Gabriel, Yasuo Kubota, Lucas H. Brennecke, Neal Stolar, Margaret Haney, Michelle R. Lofwall, Shanna Babalonis and Sharon Walsh and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Brain Research.

In The Last Decade

Steven Sparenborg

29 papers receiving 1.2k citations

Hit Papers

Bupropion and Naltrexone in Methamphetamine Use Disorder 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Sparenborg United States 18 510 402 398 196 155 29 1.2k
Arto J. Hiltunen Sweden 23 461 0.9× 201 0.5× 380 1.0× 188 1.0× 119 0.8× 66 1.3k
David M. Penetar United States 22 286 0.6× 367 0.9× 391 1.0× 145 0.7× 46 0.3× 50 1.3k
Torsten Passie Germany 24 1.1k 2.1× 189 0.5× 470 1.2× 92 0.5× 100 0.6× 50 2.7k
Valerie H. Curran United Kingdom 10 765 1.5× 206 0.5× 639 1.6× 109 0.6× 54 0.3× 15 1.9k
Richard E. Musty United States 15 700 1.4× 458 1.1× 505 1.3× 285 1.5× 28 0.2× 25 1.5k
D.J. Nutt United Kingdom 21 826 1.6× 269 0.7× 301 0.8× 65 0.3× 42 0.3× 47 2.2k
G. B. Chesher Australia 25 679 1.3× 250 0.6× 745 1.9× 152 0.8× 37 0.2× 78 1.6k
Jandira Masur Brazil 21 744 1.5× 206 0.5× 297 0.7× 200 1.0× 49 0.3× 81 1.7k
Erik W. Gunderson United States 19 458 0.9× 170 0.4× 679 1.7× 338 1.7× 237 1.5× 31 1.5k
Robert Byck United States 23 690 1.4× 229 0.6× 385 1.0× 132 0.7× 143 0.9× 49 2.0k

Countries citing papers authored by Steven Sparenborg

Since Specialization
Citations

This map shows the geographic impact of Steven Sparenborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Sparenborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Sparenborg more than expected).

Fields of papers citing papers by Steven Sparenborg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Sparenborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Sparenborg. The network helps show where Steven Sparenborg may publish in the future.

Co-authorship network of co-authors of Steven Sparenborg

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Sparenborg. A scholar is included among the top collaborators of Steven Sparenborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Sparenborg. Steven Sparenborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walker, Robrina, Maureen Hillhouse, Brian Perrochet, et al.. (2019). Medication Adherence Monitoring Using Smartphone Video Dosing in an Open-label Pilot Study of Monthly Naltrexone Plus Once-daily Bupropion for Methamphetamine Use Disorder: Feasibility and Acceptability. Journal of Addiction Medicine. 13(5). 372–378. 6 indexed citations
2.
Babalonis, Shanna, Margaret Haney, Robert Malcolm, et al.. (2016). Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers. Drug and Alcohol Dependence. 172. 9–13. 103 indexed citations
3.
Mooney, Larissa J., Maureen Hillhouse, Christie Thomas, et al.. (2016). Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder. Journal of Addiction Medicine. 10(4). 236–243. 16 indexed citations
4.
Haney, Margaret, Robert Malcolm, Shanna Babalonis, et al.. (2015). Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology. 41(8). 1974–1982. 152 indexed citations
5.
Tai, Betty, Steven Sparenborg, Udi E. Ghitza, & David Liu. (2014). Expanding the National Drug Abuse Treatment Clinical Trials Network to address the management of substance use disorders in general medical settings. SHILAP Revista de lepidopterología. 5. 75–75. 7 indexed citations
6.
Tai, Betty, Robert Lindblad, Paul VanVeldhuisen, et al.. (2014). Patient registries for substance use disorders. SHILAP Revista de lepidopterología. 5. 81–81. 6 indexed citations
7.
Winhusen, Theresa, Daniel Lewis, Gaurav Sharma, & Steven Sparenborg. (2014). A multi-site, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence. Drug and Alcohol Dependence. 146. e24–e25. 1 indexed citations
8.
Griffin, Margaret L., et al.. (2013). Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. The American Journal of Drug and Alcohol Abuse. 40(2). 157–162. 31 indexed citations
9.
Winhusen, Theresa, Kathleen T. Brady, Maxine L. Stitzer, et al.. (2012). Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: An efficacy trial conducted in the real world. Contemporary Clinical Trials. 33(5). 993–1002. 14 indexed citations
10.
Ling, Walter, Petra Jacobs, Maureen Hillhouse, et al.. (2010). From research to the real world: Buprenorphine in the decade of the Clinical Trials Network. Journal of Substance Abuse Treatment. 38. S53–S60. 37 indexed citations
11.
12.
Sparenborg, Steven. (1998). Mortality in Neonatal Rats Is Increased by Moderate Prenatal Exposure to Some Monoamine Reuptake Inhibitors: A Brief Reviewb. Annals of the New York Academy of Sciences. 846(1). 423–426. 1 indexed citations
14.
15.
Sparenborg, Steven, Lucas H. Brennecke, Nancy K. Jaax, & David J. Braitman. (1992). Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacology. 31(4). 357–368. 79 indexed citations
16.
Gabriel, Michael, et al.. (1991). Effects of cingulate cortical lesions on avoidance learning and training-induced unit activity in rabbits. Experimental Brain Research. 86(3). 585–600. 112 indexed citations
17.
Sparenborg, Steven & Michael Gabriel. (1990). Neuronal encoding of conditional stimulus duration in the cingulate cortex and the limbic thalamus of rabbits.. Behavioral Neuroscience. 104(6). 919–933. 19 indexed citations
18.
Sparenborg, Steven, et al.. (1989). Anterior and medial thalamic lesions, discriminative avoidance learning, and cingulate cortical neuronal activity in rabbits. Experimental Brain Research. 76(2). 441–57. 63 indexed citations
19.
Buskist, William, Harold L. Miller, Steven Sparenborg, Donovan E. Fleming, & Robert H. Bennett. (1982). Preference for Familiar-Positive Diet is Unaffected by Lithium Toxicosis: The Garcia Effect and Recovery From Thiamine Deficiency. The Psychological Record. 32(3). 445–450. 13 indexed citations
20.
Buskist, William, Harold L. Miller, Donovan E. Fleming, & Steven Sparenborg. (1981). Associative history, not familiarity, determines strength of taste-aversion conditioning in thiamine-deficient rats. Bulletin of the Psychonomic Society. 17(2). 104–106. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026